Eintrag weiter verarbeiten
Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience
Gespeichert in:
| Zeitschriftentitel: | Acta chirurgica Iugoslavica |
|---|---|
| Personen und Körperschaften: | , , , |
| In: | Acta chirurgica Iugoslavica, 53, 2006, 2, S. 17-21 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
National Library of Serbia
|
| Schlagwörter: |
| author_facet |
Füzün, Mehmet Sökmen, Selman Terzi, Cem Emre-Canda, Aras Füzün, Mehmet Sökmen, Selman Terzi, Cem Emre-Canda, Aras |
|---|---|
| author |
Füzün, Mehmet Sökmen, Selman Terzi, Cem Emre-Canda, Aras |
| spellingShingle |
Füzün, Mehmet Sökmen, Selman Terzi, Cem Emre-Canda, Aras Acta chirurgica Iugoslavica Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience General Medicine |
| author_sort |
füzün, mehmet |
| spelling |
Füzün, Mehmet Sökmen, Selman Terzi, Cem Emre-Canda, Aras 0354-950X 2406-0887 National Library of Serbia General Medicine http://dx.doi.org/10.2298/aci0602017f <jats:p>Peritoneal carcinomatosis (PC) in contrast to lymph nodes and liver metastases was assumed as a terminal condition with no curative treatment options having a 5 to 9 months median survival rate until recently. Today, in properly selected patients, curative surgical treatment of PC is possible like resection of lymph nodes and liver metastases. Between 1996 and 2005, 29 patients who underwent cytoreductive surgery combined with intraperitoneal chemotherapy for PC originated from colorectal cancer (CRC) were analyzed prospectively at the Department of Surgery in Dokuz Eylul University Hospital. Mean age was 54 year (range, 23-75 years). There was no peroperative mortality in 29 patients. The morbidity rate was 41% (12/29) and 6 (20%) patients required reoperation(s) for major complications. Mean and median survival time was 34 and 21 months, respectively. The overall 1-year, 3-year, and 5-year survival rates were 72%, 13%, and 7%, respectively. Mean survival time was 56 months in patients with peritoneal cancer index (PCI) <10, and 22 months in patients with PCI >10 (P=0.075). The mean survival time was 62 months in patients with complete cytoreduction (CC)-0 score, 21 months in patients with CC-1 score, and 7 months in patients with CC-2 and 3 scores. Patients who had CC-0 score had better survival than patients having CC-1 and CC-2 scores (P = 0.003 and P = 0.000, respectively). Patients who had CC-0 and 1 scores had better survival than patients with CC-2 score (P = 0.000). The overall 1-year, 3-year, and 5-year survival rates for patients with CC-0 score were 87%, 37%, and 25%, respectively. There was a positive correlation between the PCI and CC score (P = 0.001, correlation coefficient = 0.585 with correlation is significant at level 0.01). Cytoreductive approach combined with intraperitoneal chemotherapy and systemic chemotherapy prolongs survival in selected patients with PC of CRC with acceptable morbidity and mortality. Prognosis is better in patients with limited disease and in whom complete cytoreduction is achieved. In patients with PC of CRC, the key issue is to select the patients in whom complete cytoreduction is feasible. Better patient assessment with new diagnostic tools such as (PET)-CT or PET-magnetic resonance imaging will be used to detect more precisely the patients with low tumor burden in the new feature.</jats:p> Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience Acta chirurgica Iugoslavica |
| doi_str_mv |
10.2298/aci0602017f |
| facet_avail |
Online Free |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjI5OC9hY2kwNjAyMDE3Zg |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjI5OC9hY2kwNjAyMDE3Zg |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
National Library of Serbia, 2006 |
| imprint_str_mv |
National Library of Serbia, 2006 |
| issn |
0354-950X 2406-0887 |
| issn_str_mv |
0354-950X 2406-0887 |
| language |
English |
| mega_collection |
National Library of Serbia (CrossRef) |
| match_str |
fuzun2006cytoreductiveapproachtoperitonealcarcinomatosisoriginatedfromcolorectalcancerturkishexperience |
| publishDateSort |
2006 |
| publisher |
National Library of Serbia |
| recordtype |
ai |
| record_format |
ai |
| series |
Acta chirurgica Iugoslavica |
| source_id |
49 |
| title |
Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| title_unstemmed |
Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| title_full |
Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| title_fullStr |
Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| title_full_unstemmed |
Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| title_short |
Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| title_sort |
cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: turkish experience |
| topic |
General Medicine |
| url |
http://dx.doi.org/10.2298/aci0602017f |
| publishDate |
2006 |
| physical |
17-21 |
| description |
<jats:p>Peritoneal carcinomatosis (PC) in contrast to lymph nodes and liver metastases was assumed as a terminal condition with no curative treatment options having a 5 to 9 months median survival rate until recently. Today, in properly selected patients, curative surgical treatment of PC is possible like resection of lymph nodes and liver metastases. Between 1996 and 2005, 29 patients who underwent cytoreductive surgery combined with intraperitoneal chemotherapy for PC originated from colorectal cancer (CRC) were analyzed prospectively at the Department of Surgery in Dokuz Eylul University Hospital. Mean age was 54 year (range, 23-75 years). There was no peroperative mortality in 29 patients. The morbidity rate was 41% (12/29) and 6 (20%) patients required reoperation(s) for major complications. Mean and median survival time was 34 and 21 months, respectively. The overall 1-year, 3-year, and 5-year survival rates were 72%, 13%, and 7%, respectively. Mean survival time was 56 months in patients with peritoneal cancer index (PCI) <10, and 22 months in patients with PCI >10 (P=0.075). The mean survival time was 62 months in patients with complete cytoreduction (CC)-0 score, 21 months in patients with CC-1 score, and 7 months in patients with CC-2 and 3 scores. Patients who had CC-0 score had better survival than patients having CC-1 and CC-2 scores (P = 0.003 and P = 0.000, respectively). Patients who had CC-0 and 1 scores had better survival than patients with CC-2 score (P = 0.000). The overall 1-year, 3-year, and 5-year survival rates for patients with CC-0 score were 87%, 37%, and 25%, respectively. There was a positive correlation between the PCI and CC score (P = 0.001, correlation coefficient = 0.585 with correlation is significant at level 0.01). Cytoreductive approach combined with intraperitoneal chemotherapy and systemic chemotherapy prolongs survival in selected patients with PC of CRC with acceptable morbidity and mortality. Prognosis is better in patients with limited disease and in whom complete cytoreduction is achieved. In patients with PC of CRC, the key issue is to select the patients in whom complete cytoreduction is feasible. Better patient assessment with new diagnostic tools such as (PET)-CT or PET-magnetic resonance imaging will be used to detect more precisely the patients with low tumor burden in the new feature.</jats:p> |
| container_issue |
2 |
| container_start_page |
17 |
| container_title |
Acta chirurgica Iugoslavica |
| container_volume |
53 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792336251808907267 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:57:14.503Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Cytoreductive+approach+to+peritoneal+carcinomatosis+originated+from+colorectal+cancer%3A+Turkish+experience&rft.date=2006-01-01&genre=article&issn=2406-0887&volume=53&issue=2&spage=17&epage=21&pages=17-21&jtitle=Acta+chirurgica+Iugoslavica&atitle=Cytoreductive+approach+to+peritoneal+carcinomatosis+originated+from+colorectal+cancer%3A+Turkish+experience&aulast=Emre-Canda&aufirst=Aras&rft_id=info%3Adoi%2F10.2298%2Faci0602017f&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792336251808907267 |
| author | Füzün, Mehmet, Sökmen, Selman, Terzi, Cem, Emre-Canda, Aras |
| author_facet | Füzün, Mehmet, Sökmen, Selman, Terzi, Cem, Emre-Canda, Aras, Füzün, Mehmet, Sökmen, Selman, Terzi, Cem, Emre-Canda, Aras |
| author_sort | füzün, mehmet |
| container_issue | 2 |
| container_start_page | 17 |
| container_title | Acta chirurgica Iugoslavica |
| container_volume | 53 |
| description | <jats:p>Peritoneal carcinomatosis (PC) in contrast to lymph nodes and liver metastases was assumed as a terminal condition with no curative treatment options having a 5 to 9 months median survival rate until recently. Today, in properly selected patients, curative surgical treatment of PC is possible like resection of lymph nodes and liver metastases. Between 1996 and 2005, 29 patients who underwent cytoreductive surgery combined with intraperitoneal chemotherapy for PC originated from colorectal cancer (CRC) were analyzed prospectively at the Department of Surgery in Dokuz Eylul University Hospital. Mean age was 54 year (range, 23-75 years). There was no peroperative mortality in 29 patients. The morbidity rate was 41% (12/29) and 6 (20%) patients required reoperation(s) for major complications. Mean and median survival time was 34 and 21 months, respectively. The overall 1-year, 3-year, and 5-year survival rates were 72%, 13%, and 7%, respectively. Mean survival time was 56 months in patients with peritoneal cancer index (PCI) <10, and 22 months in patients with PCI >10 (P=0.075). The mean survival time was 62 months in patients with complete cytoreduction (CC)-0 score, 21 months in patients with CC-1 score, and 7 months in patients with CC-2 and 3 scores. Patients who had CC-0 score had better survival than patients having CC-1 and CC-2 scores (P = 0.003 and P = 0.000, respectively). Patients who had CC-0 and 1 scores had better survival than patients with CC-2 score (P = 0.000). The overall 1-year, 3-year, and 5-year survival rates for patients with CC-0 score were 87%, 37%, and 25%, respectively. There was a positive correlation between the PCI and CC score (P = 0.001, correlation coefficient = 0.585 with correlation is significant at level 0.01). Cytoreductive approach combined with intraperitoneal chemotherapy and systemic chemotherapy prolongs survival in selected patients with PC of CRC with acceptable morbidity and mortality. Prognosis is better in patients with limited disease and in whom complete cytoreduction is achieved. In patients with PC of CRC, the key issue is to select the patients in whom complete cytoreduction is feasible. Better patient assessment with new diagnostic tools such as (PET)-CT or PET-magnetic resonance imaging will be used to detect more precisely the patients with low tumor burden in the new feature.</jats:p> |
| doi_str_mv | 10.2298/aci0602017f |
| facet_avail | Online, Free |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjI5OC9hY2kwNjAyMDE3Zg |
| imprint | National Library of Serbia, 2006 |
| imprint_str_mv | National Library of Serbia, 2006 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 0354-950X, 2406-0887 |
| issn_str_mv | 0354-950X, 2406-0887 |
| language | English |
| last_indexed | 2024-03-01T14:57:14.503Z |
| match_str | fuzun2006cytoreductiveapproachtoperitonealcarcinomatosisoriginatedfromcolorectalcancerturkishexperience |
| mega_collection | National Library of Serbia (CrossRef) |
| physical | 17-21 |
| publishDate | 2006 |
| publishDateSort | 2006 |
| publisher | National Library of Serbia |
| record_format | ai |
| recordtype | ai |
| series | Acta chirurgica Iugoslavica |
| source_id | 49 |
| spelling | Füzün, Mehmet Sökmen, Selman Terzi, Cem Emre-Canda, Aras 0354-950X 2406-0887 National Library of Serbia General Medicine http://dx.doi.org/10.2298/aci0602017f <jats:p>Peritoneal carcinomatosis (PC) in contrast to lymph nodes and liver metastases was assumed as a terminal condition with no curative treatment options having a 5 to 9 months median survival rate until recently. Today, in properly selected patients, curative surgical treatment of PC is possible like resection of lymph nodes and liver metastases. Between 1996 and 2005, 29 patients who underwent cytoreductive surgery combined with intraperitoneal chemotherapy for PC originated from colorectal cancer (CRC) were analyzed prospectively at the Department of Surgery in Dokuz Eylul University Hospital. Mean age was 54 year (range, 23-75 years). There was no peroperative mortality in 29 patients. The morbidity rate was 41% (12/29) and 6 (20%) patients required reoperation(s) for major complications. Mean and median survival time was 34 and 21 months, respectively. The overall 1-year, 3-year, and 5-year survival rates were 72%, 13%, and 7%, respectively. Mean survival time was 56 months in patients with peritoneal cancer index (PCI) <10, and 22 months in patients with PCI >10 (P=0.075). The mean survival time was 62 months in patients with complete cytoreduction (CC)-0 score, 21 months in patients with CC-1 score, and 7 months in patients with CC-2 and 3 scores. Patients who had CC-0 score had better survival than patients having CC-1 and CC-2 scores (P = 0.003 and P = 0.000, respectively). Patients who had CC-0 and 1 scores had better survival than patients with CC-2 score (P = 0.000). The overall 1-year, 3-year, and 5-year survival rates for patients with CC-0 score were 87%, 37%, and 25%, respectively. There was a positive correlation between the PCI and CC score (P = 0.001, correlation coefficient = 0.585 with correlation is significant at level 0.01). Cytoreductive approach combined with intraperitoneal chemotherapy and systemic chemotherapy prolongs survival in selected patients with PC of CRC with acceptable morbidity and mortality. Prognosis is better in patients with limited disease and in whom complete cytoreduction is achieved. In patients with PC of CRC, the key issue is to select the patients in whom complete cytoreduction is feasible. Better patient assessment with new diagnostic tools such as (PET)-CT or PET-magnetic resonance imaging will be used to detect more precisely the patients with low tumor burden in the new feature.</jats:p> Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience Acta chirurgica Iugoslavica |
| spellingShingle | Füzün, Mehmet, Sökmen, Selman, Terzi, Cem, Emre-Canda, Aras, Acta chirurgica Iugoslavica, Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience, General Medicine |
| title | Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| title_full | Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| title_fullStr | Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| title_full_unstemmed | Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| title_short | Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| title_sort | cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: turkish experience |
| title_unstemmed | Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| topic | General Medicine |
| url | http://dx.doi.org/10.2298/aci0602017f |